Archil Jaliashvili: What if Normal Hb and SpO₂ Still Do not Mean Adequate Tissue Oxygenation?
Archil Jaliashvili, Co-Chief Executive Officer at GeoBio Pharm, Biotech Executive, Strategic Partner of BHOC and Precision Oxygen Therapeutics, shared a post on LinkedIn:
“What if normal Hb and SpO₂ still do not mean adequate tissue oxygenation?
This new review raises exactly this question.
In severe inflammation and critical illness, the problem is not simply how much oxygen is present in the blood.
- Endothelial dysfunction.
- Microcirculatory impairment.
- Edema.
- Microthrombosis.
- Altered NO biology.
- Longer oxygen diffusion distance.
All of these can determine whether oxygen actually reaches the tissue.
This is why I believe we need to move beyond thinking only in terms of hemoglobin, saturation and macrocirculation.
We need a broader concept: Precision Oxygenation Therapeutics.
The therapeutic objective should not simply be to improve numbers in the bloodstream.
It should be to maintain effective oxygen availability where it is actually needed at the tissue level.
This also creates an important research question for BHOC and next-generation HBOCs.
Not as a replacement for RBCs.
But as a complementary oxygen-delivery platform that may help support tissue oxygenation when conventional RBC-dependent transport, endothelial
regulation and microcirculation become physiologically limited.
The future question may therefore be less:
‘How much hemoglobin do we have?’
and more:
‘How much oxygen is actually reaching the tissue and can we control this more precisely?'”
Title: The Potential for Severe, Acute Inflammation to Impact Tissue Oxygenation—A Narrative Review
Authors: Alan Nimmo, Alexander Younsi
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026